Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study

Nickel, M. and Moleda, D. and Loew, T. and Rother, W. and Gil, F. Pedrosa (2007) Cabergoline treatment in men with psychogenic erectile dysfunction: a randomized, double-blind, placebo-controlled study. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 19 (1). pp. 104-107. ISSN 0955-9930,

Full text not available from this repository. (Request a copy)

Abstract

The effectiveness of cabergoline in 50 men with psychogenic erectile dysfunction was investigated in a 4-month, randomized, placebo-controlled, double-blind study with validated psychological tests, and prolactin, follicle-stimulating hormone, luteinizing hormone and testosterone serum levels. Cabergoline treatment was well-tolerated and resulted in normalization of hormone levels in most cases. In the cabergoline-treated group, significant interactions between prolactin and testosterone serum concentrations were observed. Erectile function improved significantly. Sexual desire, orgasmic function, and the patient's and his partner's sexual satisfaction were also enhanced. Cabergoline may be an effective and safe alternative agent for men with psychogenic ED.

Item Type: Article
Uncontrolled Keywords: HYPERPROLACTINEMIA; psychogenic erectile dysfunction; libido; cabergoline; prolactin; testosterone; quality of life
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Abteilung für Psychosomatische Medizin
Depositing User: Dr. Gernot Deinzer
Date Deposited: 12 Jan 2021 09:38
Last Modified: 12 Jan 2021 09:41
URI: https://pred.uni-regensburg.de/id/eprint/33434

Actions (login required)

View Item View Item